Optimising outcomes: socioeconomic perspective.
Mark
D B
DB
Outcomes Research and Assessment Group, Department of Medicine, Cardiovascular Division, Box 3485, Duke University Medical Center, Durham, NC 27710, USA.
D000789:Angina, Unstable / Q000188:drug therapy* / Q000191:economics; D015906:Angioplasty, Balloon, Coronary; D000925:Anticoagulants / Q000191:economics / Q000627:therapeutic use*; D017046:Cost Savings; D004311:Double-Blind Method; D016527:Drug Costs; D017984:Enoxaparin / Q000191:economics / Q000627:therapeutic use*; D005343:Fibrinolytic Agents / Q000191:economics / Q000627:therapeutic use*; D017721:Hospital Costs; D006801:Humans; D007902:Length of Stay / Q000191:economics; D016032:Randomized Controlled Trials as Topic; D012959:Socioeconomic Factors
D000925:Anticoagulants; D017984:Enoxaparin; D005343:Fibrinolytic Agents